Improvements in closed-loop processing and lower material costs could bring distributed manufacturing within reach. Hospitals still need to stand up production suites.
- An Incomplete Response: Will The FDA Finish What It Started With Real-Time CRLs?
- Navigating Outsourced Pharmaceutical Testing Through Today's Geopolitical Uncertainty
- Is Your Supply Chain Ready For The End Of Class VI?
- Demonstrating Gene Therapy Potency: A Strategic Road Map
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- When Lyophilization Fails At Scale, First Scrutinize Your Formulation
- The 5 Shifts That Could Remake Lyophilization By 2040
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
5 Must-Haves For Electronic Batch Records In Life Sciences
Companies still relying on paper-based manufacturing are falling behind. Examine how digital transformation boosts efficiency and reduces errors in this essential shift toward smarter operations.
-
Standardizing Cryopreservation For Cell Therapy Supply Chains
Explore how a standardized cryopreservation process is transforming leukapheresis handling by reducing risk and improving quality across the cell therapy supply chain.
-
3-In-1 Protocol For Rapid CAR-T Cell Manufacturing
Closing the process and merging three steps into one perfusion run brings CAR-T manufacturing down to roughly a week, with fewer open events and lower batch failure risk.
-
How Isogenic Organ-Chips Are Transforming The Future Of Research
Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.
-
SaniSure Clamp: Design And Technical Advantages
Traditional sanitary clamps can create sealing inconsistencies with single-use components. Discover a compression-based approach that improves gasket performance and reduces leak risks.
-
Case Study: The Right Ratio – Building An End-To-End DAR Strategy For ADC Success
When developing antibody-drug conjugates (ADCs), a robust drug-to-antibody ration (DAR) strategy isn’t just nice to have — it's mission-critical.
-
Efficient Protein Purification Strategies
Examine two rapid, high‑throughput strategies for small‑scale protein separation, using either multimodal resins or ion exchange membranes to achieve efficient, low‑volume purification.
-
Performance Comparison Of The Vericheck ddPCR™ Empty-Full Capsid Kit And Analytical Ultracentrifugation (AUC)
Discover how Droplet Digital PCR (ddPCR) offers a precise analysis of AAV capsid content, outperforming analytical ultracentrifugation (AUC) in distinguishing therapeutic genomes from contaminants.
-
Engineering Precision In Genetic Medicines
Explore how protein discovery, PAM engineering, and AI-guided optimization can expand target coverage, improve editing specificity, and address challenging therapeutic applications.
-
Automated Manufacturing Of CD34-Enriched Cell Products
See how this streamlined approach produces high-quality CD34+ cell products from cryopreserved apheresis material, integrating thawing, washing, and enrichment into a single automated workflow.
NEWSLETTER ARCHIVE
- 10.30.26 -- What Regionalized Filtration Networks Mean For Biopharma
- 10.30.26 -- Why Clinical Trial Design Matters For MSC Success
- 10.29.26 -- Expert Insights On Choosing The Right CGT Manufacturing Model
- 10.28.26 -- Accelerating Advanced Therapies: From Development To Manufacturing
- 10.28.26 -- The Manufacturing Reality Behind Advanced Therapy Commercial Scale
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
- What LSPA's Life Sciences Future Says About The Road Ahead For CGT
- Inside Scaling Next-Gen MSCs Without Scaling Risk
- Inside Kyverna's Autoimmune CAR T Platform Beyond SPS
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

